Home|Journals|Articles by Year

Directory for Medical Articles

Research Article

Bakri balloon in the management of postpartum haemorrhage – a single centre experience

Tihomir Totev, Mila Kayryakova, Georgi Stamenov.


Introduction: Postpartum haemorrhage (PPH) remains a leading cause of maternal morbidity and mortality and sometimes requires a hysterectomy. Several studies have shown the haemostatic effectiveness of a Bakri intrauterine haemostatic balloon, and this needs further examination in a single-centre study. Materials and methods: This is an observational cohort retrospective single-centre study evaluating the effect of a Bakri balloon tamponade on the reduction of the rate of postpartum hysterectomy. Results: A total of 96 patients were treated for PPH resistant to pharmacological measures and were included in this study. In 88 (91.7%) patients, the Bakri balloon tamponade was performed during or after a caesarean section. The indication for the Bakri balloon was as follows: 73 (76%) for uterine atony; 7 (7.3%) for placenta accreta spectrum; 4 (4.2%) for retained placenta; 6 (6.3%) for secondary PPH; 5 (5.2%) for laceration of the genital tract, and 1 (1%) for uncontrolled bleeding from an intramural leiomyoma. Bakri balloon achieved hemostasis in 91 (94.8%), and the remaining 5 (5.2%) required a hysterectomy, 47,9% of the patients had undergone laparoscopic or hysteroscopic interventions, and 60,4% had conceived after IVF procedures. Conclusions: This single-centre study identified the Bakri balloon tamponade as an effective treatment for PPH.

Key words: Postpartum haemorrhage, Bakri balloon, hysterectomy

Full-text options

Share this Article

Online Article Submission
• ejmanager.com
• ojshosting.net

Do you want to use OJS for your journal ?
work with an experienced partner

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.